Amvona

Lemelson Capital Management Featured in Activist Insight

Lemelson Capital Management Logo resized to 220 px

*Please read the full notice and disclaimer at the bottom of this page.

Lemelson Capital Management Featured in the January 23, 2018 addition of Activist Insight

"CEO Patrick Doyle is 'exiting before the chickens come home to roost'... "Doyle has turned Domino's into a financial house of cards, fleeced shareholders by dramatically increasing the shareholder deficit and borrowed recklessly to 'juice' the stock price which in turn enriches him,' "

Activist Insight provides the most comprehensive information on activist investing worldwide, providing unmatched intelligence to professionals in the global activist investment space and is the only monthly magazine dedicated to shareholder activism, granting its readership access to the thoughts and opinions of key industry professionals.

Lemelson: Domino's has the worst corporate governance by amvona on Scribd

  • Read 752 times
Read more...

Lemelson Capital Management announces 10 percent stake in Geospace Technologies (NASDAQ: GEOS), urges immediate share repurchase

Lemelson Capital Management Logo resized to 220 px

Lemelson Capital Management announces 10 percent stake in Geospace Technologies (NASDAQ: GEOS), urges immediate share repurchase

Firm reiterates near-term intrinsic value at $38 per share

Marlborough, MA, December 1, 2017—Lemelson Capital Management, LLC, a private investment management firm, announced today it has acquired, for its flagship Amvona Fund, LP, a stake of approximately 10 percent in shares of Geospace Technologies (NASDAQ: GEOS), a global leader in the design and manufacture of instruments and equipment used by the oil and gas industry. In addition, it is urging the company to initiate an immediate share repurchase plan.

  • Read 4716 times
Read more...

Listen to Fr. Emmanuel live discussing an update on The Amvona Fund, LP's recent investments as well as thoughts on the markets

Lemelson Capital Management Logo resized to 220 px*Please read the full notice and disclaimer at the bottom of this page.

Listen to Fr. Emmanuel live on November 10, 2017 discussing an update on The Amvona Fund, LP's recent investments in the retail sector.

“…honestly, I thought it [Hibbet Sports] was one of the best value investments we had come across in the last seven years… we loaded-up substantially… we bought a huge block of shares between $9.40 per share and $9.50 per share, I couldn’t believe it, the price”

“some of the things people are saying about them [Hibbett] are not really rational, like saying, ‘it’s too little too late for their ecommerce’… why would you bet that they’re not going to benefit from having an ecommerce business? I think they’re going to do their omni-channel business extremely well… it’s an incredibly well-run business, I think it’s going to be a home-run for us… we already have a very significant rate of return…”

Interview includes an update on the fund's stakes in:

  • American Eagle Outfitters (NYSE: AEO)
  • Guess (NYSE: GES)
  • Express  (NYSE: EXPR) 
  • Hibbett Sports (NASDAQ: HIBB)
  • Domino's Pizza (NYSE: DPZ)

Commentary also includes an in-depth discussion of the market, macro-economic issues, and an update on the performance of the above commitments since the last interview on August 25, 2017.

Listen to the full interview here.

  • Read 2396 times
Read more...

Listen to Fr. Emmanuel live discussing The Amvona Fund, LP's investments in the retail sector and more

Lemelson Capital Management Logo resized to 220 px*Please read the full notice and disclaimer at the bottom of this page.

Listen to Fr. Emmanuel live discussing The Amvona Fund, LP's recent investments in the retail sector.

Interview includes discussion of the fund's stakes in:

  • American Eagle Outfitters (NYSE: AEO)
  • Guess (NYSE: GES)
  • Express  (NYSE: EXPR) 
  • Hibbett Sports (NASDAQ: HIBB)
  • Domino's Pizza (NYSE: DPZ)

Commentary includes discussion of Amazon (NASDAQ: AMZN) and it's recent purchase of WholeFoods Market, implications for Costco Wholesale (NASDAQ: COST) as well as an extensive discussion of regulatory and accounting abuses in the pharmaceutical industry. 

Listen to the full interview here.

  • Read 2419 times
Read more...

Lantern Foundation Founder Urges Senate Committee to Commence Investigation into Ligand Pharmaceuticals

Lantern Foundation Founder Urges Senate Committee to Commence Investigation into Ligand Pharmaceuticals (NASDAQ: LGND)

Abuse of Orphan Drug Act, Accounting and Ethical Violations Warrant Congressional and Regulatory Investigation, Organization’s Founder Says

MARLBOROUGH, Mass., Dec. 21, 2016 /PRNewswire/ -- Rev. Fr. Emmanuel Lemelson, the founder and president of The Lantern Foundation, a U.S.-based non-profit foundation, today released a letter he has provided the U.S. Senate Special Committee on Aging, summarizing extensive alleged abuses of accounting, pharmaceutical reimbursement and classification guidelines and regulations by Ligand Pharmaceuticals (NASDAQ: LGND), a U.S.-based publicly-traded pharmaceutical company.  In the letter, Lemelson urged the Committee to commence an investigation into these alleged abuses, which he says resemble those committed by Retrophin chief executive officer Martin Shkreli, who was charged with securities fraud by the U.S. Federal Bureau of Investigation (FBI) in December 2015.   

The full letter to the U.S. Senate Special Committee on Aging’s Chairwoman and Ranking Minority Member, released this morning, is available here

“After several years researching the business practices of Ligand, a clear pattern of unethical conduct has emerged, including abuse of accounting loopholes and guidelines and misuse of the Orphan Drug Act of 1983, which has been used to increase the prices of its drugs dramatically,” Lemelson said today.   

The two costly drugs cited in today’s letter to the Senate Committee, Kyprolis and Promacta, are among the nation’s most exorbitantly priced, selling at $280,000 per round of treatment and $10,196 for thirty 75 mg. tablets respectively.  

Lemelson today simultaneously announced that he would be urging the U.S. Food and Drug Administration, U.S. Department of Health and Human Services, and other appropriate federal and state regulatory and investigatory bodies to evaluate whether, in these and other business practices, Ligand has abused the Orphan Drug Act and other statutes and regulations.

Additionally, following Lemelson’s identification of multiple accounting violations and misrepresentations by Ligand earlier this year, including the company’s overstating the value of certain deferred tax assets by approximately $27.5 million,  misclassifying its debt, and abusing the variable interest entity standard, Lemelson said today that he filed a whistleblower report earlier this year with the U.S. Securities and Exchange Commission (SEC), urging the SEC to evaluate whether these alleged abuses constitute violations of civil or criminal statutes.  

 
About Rev. Fr. Emmanuel Lemelson

Rev. Fr. Emmanuel Lemelson is the founder and president of The Lantern Foundation, established in December of 2012 as a U.S.-based 501c(3) private foundation, and chief investment officer of Lemelson Capital Management, LLC a Massachusetts based investment management firm

For more information, see: http://www.phanarion.org and https://www.lemelsoncapital.com/  

For further information, please contact:

Lemelson Capital Management, LLC 
Investor and Media Relations 
Telephone: 508-630-2281

 
SOURCE: The Lantern Foundation

Fr. Emmanuel Lemelson Letter to Congress Regarding Ligand by amvona on Scribd

  • Read 4426 times
Read more...

“Be very careful” Listen to Fr. Emmanuel discuss the risks at Alibaba 17 months before SEC announces investigation into firm

Lemelson discusses the risks associated with investing in Alibaba (NYSE: BABA) in January 2015 (17 months before the SEC announces investigation into firm). Discussion includes descrepencies between the firm's reported shipping figures and carrier capacities as well as commentary on the risks of investing in IPO's in general, particularly Chinese IPO's.  Shares of Alibaba traded around ~$100 per share at the time.

  • Read 9439 times
Read more...

$100 Million Defamation Suit Filed against Bloomberg L.P., Reporter Matt Robinson and Editor Jesse Westbrook

$100 Million Defamation Suit Filed against Bloomberg L.P., Reporter Matt Robinson and Editor Jesse Westbrook

Marlborough, Mass., May 10, 2016— Bloomberg, L.P. and two Bloomberg employees, Jesse Westbrook, a Bloomberg editor, and Matt Robinson, a Bloomberg reporter, were sued today for defamation in Massachusetts Superior Court. The plaintiff, Father Emmanuel Lemelson, seeks $100 million in compensatory damages for defamation in a March 18, 2016 Bloomberg article by Robinson.

  • Read 5565 times
Read more...

Excerpt From The Amvona Fund, LP's 2015 Annual Report On Geospace Technologies

"Like all great investments, it requires patience. We've said from day one, we'd be happy if we realized we were right after two years. We're about eight or nine months into that… we're just going to keep buying for the next four or five months and hopefully we'll get 10 percent of the company."

Benzinga PreMarket Prep Show, June 5, 2015[1]

  • Read 5601 times
Read more...

Update: Lemelson Capital Fox Business News short call on Netflix (Nasdaq: NFLX)

On November 5, 2015 Rev. Fr. Emmanuel Lemelson appeared on Fox Business News discussing amongst other topics a short call in shares of NetFlix (NASDAQ: NFLX).

On November 24th, 2015 Lemelson Capital significantly increased the size of its short stake in shares NFLX – the aggregate short price ended at $122.81. The shares closed on Friday, February 5th at $82.79 a decline in value / return of 32.6% in just over two months.

  • Read 3086 times
Read more...

Don't
Hesitate To
Contact Us

 

225 Cedar Hill Street Suite #200 Marlborough MA 01752 USA

Feel free to email us. We would be happy to answer any questions you might have.


Copyright © 2017 Amvona